Skip to main content

MORGAN STANLEY

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY

Position in CRVS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$36,557,808
+$9,084,919 QoQ
Shares Held
2,498,825
-30.0% QoQ
Ownership
2.97%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 81.07258411453383.ToString("F0")% Shared 0.ToString("F0")% None 18.92741588546617.ToString("F0")%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. CRVS ranks #64 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $36,557,808 2,498,825
2025-12-31 $27,472,889 3,567,908
2025-09-30 $4,548,940 617,224
2025-06-30 $3,577,620 894,405
2025-03-31 $2,141,805 673,524
2024-12-31 $2,125,896 397,364
2024-09-30 $2,076,422 393,262
2024-06-30 $675,952 371,403
2024-03-31 $490,141 275,361
2023-12-31 $456,992 259,655
2023-09-30 $281,057 192,506
2023-06-30 $319,763 139,635
2023-03-31 $91,144 100,159
2022-12-31 $61,713 72,605
2022-09-30 $32,199 39,317
2022-06-30 $48,853 49,348
2022-03-31 $67,012 40,862
2021-12-31 $88,869 36,876
2021-09-30 $144,924 29,943
2021-06-30 $99,120 37,124
2021-03-31 $114,738 37,253
2020-12-31 $135,077 37,943
2020-09-30 $131,311 32,746
2020-06-30 $40,914 15,042
2020-03-31 $69,461 32,920